Eric Vivier | Academic Influence

Eric Vivier's AcademicInfluence.com Rankings

Eric Vivier

Biology

#4055

World Rank

#6106

Historical Rank

Immunology

#184

World Rank

#192

Historical Rank

biology Degrees

Download Badge

Biology

Eric Vivier's Degrees

PhD Immunology Université Paris Cité
Masters Biology Université Paris Cité
Bachelors Biochemistry Université Paris Cité

Similar Degrees You Can Earn

Best Online Master's in Biology

Why Is Eric Vivier Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Eric Vivier is a French professor of immunology at Aix-Marseille and hospital practitioner at Marseille Public University Hospital. He is also Chief Scientific Officer at Innate Pharma, coordinator of the Marseille Immunopôle immunology cluster, and president of the Paris-Saclay Cancer Cluster, the first biocluster selected by the French government as part of the France 2030 program.

(See a Problem?)

Eric Vivier's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Functions of natural killer cells (2008) (3118)
Innate or Adaptive Immunity? The Example of Natural Killer Cells (2011) (2313)
Innate lymphoid cells — a proposal for uniform nomenclature (2013) (2061)
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide (2013) (1421)
Innate Lymphoid Cells: 10 Years On (2018) (1139)
Human NK cell education by inhibitory receptors for MHC class I. (2006) (1135)
TLR3 Deficiency in Patients with Herpes Simplex Encephalitis (2007) (1023)
CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner (2005) (836)
Targeting natural killer cells and natural killer T cells in cancer (2012) (730)
Natural Killer Cell Signaling Pathways (2004) (666)
Maturation of mouse NK cells is a 4-stage developmental program. (2009) (646)
Natural-killer cells and dendritic cells: "l'union fait la force". (2005) (631)
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells (2018) (629)
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans (2009) (615)
Natural killer cells and other innate lymphoid cells in cancer (2018) (575)
Influence of the transcription factor RORγt on the development of NKp46+ cell populations in gut and skin (2009) (557)
Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling (2008) (534)
Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46 (2007) (500)
Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D (2002) (491)
A novel dendritic cell subset involved in tumor immunosurveillance (2006) (448)
Altered T cell development in mice with a targeted mutation of the CD3‐epsilon gene. (1995) (419)
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells (2017) (410)
Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. (2005) (406)
Selective predisposition to bacterial infections in IRAK-4–deficient children: IRAK-4–dependent TLRs are otherwise redundant in protective immunity (2007) (396)
Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor (2007) (392)
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. (2009) (380)
Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. (1996) (380)
Immunoreceptor Tyrosine-based Inhibition Motifs (2012) (379)
Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells. (2009) (373)
Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. (1993) (369)
Harnessing innate immunity in cancer therapy (2019) (369)
Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis (2020) (336)
Immunoreceptor tyrosine‐based inhibition motifs: a quest in the past and future (2008) (326)
Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors (2011) (309)
Cutting Edge: Priming of NK Cells by IL-181 (2008) (297)
Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor (2011) (291)
The metabolic checkpoint kinase mTOR is essential for interleukin-15 signaling during NK cell development and activation (2014) (284)
NK Cell Responsiveness Is Tuned Commensurate with the Number of Inhibitory Receptors for Self-MHC Class I: The Rheostat Model 1 (2009) (279)
Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. (1997) (277)
CD8 modulation of T-cell antigen receptor–ligand interactions on living cytotoxic T lymphocytes (1995) (274)
Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses. (2007) (272)
The trafficking of natural killer cells (2007) (261)
Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future (2004) (261)
Innate lymphoid cells: major players in inflammatory diseases (2017) (259)
High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice (2018) (258)
Evidence of innate lymphoid cell redundancy in humans (2016) (252)
Natural cytotoxicity receptors and their ligands (2014) (250)
Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies. (2013) (250)
Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency. (2012) (249)
Inhibition of antigen‐induced T cell response and antibody‐induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP‐1 and SHP‐2 protein‐tyrosine phosphatases (1998) (244)
Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies. (2019) (236)
PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma (2016) (234)
Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells. (2005) (231)
Flt3 Ligand Promotes the Generation of a Distinct CD34+Human Natural Killer Cell Progenitor That Responds to Interleukin-15 (1998) (225)
Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition? (2002) (222)
The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1. (1998) (221)
TCR/CD3 coupling to Fas-based cytotoxicity (1995) (216)
T cell development in mice lacking the CD3‐zeta/eta gene. (1993) (216)
Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis (2012) (215)
A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment. (2018) (212)
Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. (1991) (208)
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity (2019) (204)
Tuning of Natural Killer Cell Reactivity by NKp46 and Helios Calibrates T Cell Responses (2012) (201)
Impaired Synaptic Function in the Microglial KARAP/DAP12-Deficient Mouse (2004) (199)
NK cell MHC class I specific receptors (KIR): from biology to clinical intervention. (2012) (199)
Complementarity and redundancy of IL-22-producing innate lymphoid cells (2015) (198)
Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1. (2014) (191)
Transforming Growth Factor-β Signaling Guides the Differentiation of Innate Lymphoid Cells in Salivary Glands. (2016) (187)
FHL2 Regulates Natural Killer Cell Development and Activation during Streptococcus pneumoniae Infection (2017) (187)
CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. (2016) (184)
Natural Killer Cells Promote Early CD8 T Cell Responses against Cytomegalovirus (2007) (183)
Membrane nanotubes facilitate long-distance interactions between natural killer cells and target cells (2010) (182)
Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice. (2000) (179)
Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair? (2009) (178)
Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum. (2005) (176)
Gene Structure, Expression Pattern, and Biological Activity of Mouse Killer Cell Activating Receptor-associated Protein (KARAP)/DAP-12* (1998) (171)
Mouse mast cell gp49B1 contains two immunoreceptor tyrosine-based inhibition motifs and suppresses mast cell activation when coligated with the high-affinity Fc receptor for IgE. (1996) (171)
NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors (2012) (169)
Innate and adaptive immunity: specificities and signaling hierarchies revisited (2004) (167)
Conservation of structural features reveals the existence of a large family of inhibitory cell surface receptors and noninhibitory/activatory counterparts. (1997) (167)
Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors (2004) (163)
The Membrane-Proximal Immunoreceptor Tyrosine-Based Inhibitory Motif Is Critical for the Inhibitory Signaling Mediated by Siglecs-7 and -9, CD33-Related Siglecs Expressed on Human Monocytes and NK Cells1 (2004) (163)
Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways. (2008) (162)
Natural killer cells: from CD3(-)NKp46(+) to post-genomics meta-analyses. (2007) (159)
Differential association of phosphatases with hematopoietic co‐receptors bearing immunoreceptor tyrosine‐based inhibition motifs (1997) (158)
The brave new world of innate lymphoid cells (2014) (151)
KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions (2005) (149)
Identity, regulation and in vivo function of gut NKp46+RORγt+ and NKp46+RORγt− lymphoid cells (2011) (148)
Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells (2014) (147)
Natural killer cells in human autoimmune diseases (2010) (145)
Outside-in Signaling Pathway Linked to CD146 Engagement in Human Endothelial Cells* (2001) (144)
Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases (2002) (143)
The speed of change: towards a discontinuity theory of immunity? (2013) (142)
Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2 (2019) (142)
Targeting natural killer cells in solid tumors (2019) (141)
Signaling pathways engaged by NK cell receptors: double concerto for activating receptors, inhibitory receptors and NK cells. (2000) (140)
Syk Regulation of Phosphoinositide 3-Kinase-Dependent NK Cell Function1 (2002) (136)
Nfil3-independent lineage maintenance and antiviral response of natural killer cells (2013) (135)
Confinement of Activating Receptors at the Plasma Membrane Controls Natural Killer Cell Tolerance (2011) (135)
Cutting Edge: CD8+ T Cell Priming in the Absence of NK Cells Leads to Enhanced Memory Responses (2011) (134)
Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors. (1999) (133)
Pivotal Role of KARAP/DAP12 Adaptor Molecule in the Natural Killer Cell–mediated Resistance to Murine Cytomegalovirus Infection (2002) (130)
Reconstituted Killer Cell Inhibitory Receptors for Major Histocompatibility Complex Class I Molecules Control Mast Cell Activation Induced via Immunoreceptor Tyrosine-based Activation Motifs* (1997) (130)
Monalizumab: inhibiting the novel immune checkpoint NKG2A (2019) (129)
Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells (2001) (127)
Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions. (2013) (127)
Transduction of cytotoxic signals in natural killer cells: a general model of fine tuning between activatory and inhibitory pathways in lymphocytes (1997) (126)
Dendritic cell regulation of carbon tetrachloride–induced murine liver fibrosis regression (2012) (124)
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape (2015) (123)
The evolution of innate lymphoid cells (2016) (122)
Early signaling via inhibitory and activating NK receptors. (2000) (119)
Tumor-Infiltrating Natural Killer Cells. (2020) (117)
Transcription factor Foxo1 is a negative regulator of natural killer cell maturation and function. (2015) (116)
Immunological memory within the innate immune system (2014) (116)
Loss of HIF-1α in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesis (2017) (115)
[Innate lymphoid cells]. (2017) (113)
SHP-1-mediated inhibitory signals promote responsiveness and anti-tumour functions of natural killer cells (2014) (113)
Tyrosine phosphorylation of the Fc gamma RIII(CD16): zeta complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing. (1991) (113)
Natural killer cell–dendritic cell crosstalk in the initiation of immune responses (2005) (111)
Coordinated Expression of Ig-Like Inhibitory MHC Class I Receptors and Acquisition of Cytotoxic Function in Human CD8+ T Cells1 (2004) (109)
Essential Role of DAP12 Signaling in Macrophage Programming into a Fusion-Competent State (2008) (108)
Endogenous glucocorticoids control host resistance to viral infection through the tissue-specific regulation of PD-1 expression on NK cells (2018) (108)
Association of signal‐regulatory proteins β with KARAP/DAP‐12 (2000) (108)
NCR3/NKp30 Contributes to Pathogenesis in Primary Sjögren’s Syndrome (2013) (107)
Activation of Human Endothelial Cells via S-Endo-1 Antigen (CD146) Stimulates the Tyrosine Phosphorylation of Focal Adhesion Kinase p125FAK * (1998) (106)
New nomenclature for MHC receptors (2001) (105)
TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells (2013) (104)
Multiplicity and plasticity of natural killer cell signaling pathways. (2006) (103)
Modification of P-selectin glycoprotein ligand-1 with a natural killer cell-restricted sulfated lactosamine creates an alternate ligand for L-selectin. (2000) (103)
Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15. (1998) (101)
Shp-2 Is Dispensable for Establishing T Cell Exhaustion and for PD-1 Signaling In Vivo. (2018) (100)
CD8β Increases CD8 Coreceptor Function and Participation in TCR–Ligand Binding (1996) (100)
Regulation of Inhibitory and Activating Killer-Cell Ig-Like Receptor Expression Occurs in T Cells After Termination of TCR Rearrangements1 (2001) (98)
Molecular Basis of the Recruitment of the SH2 Domain-containing Inositol 5-Phosphatases SHIP1 and SHIP2 by FcγRIIB* (2000) (98)
B7-H6/NKp30 interaction: a mechanism of alerting NK cells against tumors (2011) (94)
Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis (2008) (94)
Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis (2007) (94)
Natural killer cell immunotherapies against cancer: checkpoint inhibitors and more. (2017) (92)
Selective Activation of the c-Jun NH2-terminal Protein Kinase Signaling Pathway by Stimulatory KIR in the Absence of KARAP/DAP12 in CD4+ T Cells (2003) (92)
Crystal Structure of the Human Natural Killer Cell Activating Receptor KIR2DS2 (CD158j) (2003) (91)
Regulation of T cell function by NK cell receptors for classical MHC class I molecules. (2000) (89)
Cutting Edge: Eomesodermin Is Sufficient To Direct Type 1 Innate Lymphocyte Development into the Conventional NK Lineage (2016) (89)
Loss or mismatch of MHC class I is sufficient to trigger NK cell‐mediated rejection of resting lymphocytes in vivo – role of KARAP/DAP12‐dependent and ‐independent pathways (2004) (88)
Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency (2017) (87)
Biology of T memory type 1 cells (2001) (87)
The Helix-Loop-Helix Protein ID2 Governs NK Cell Fate by Tuning Their Sensitivity to Interleukin-15. (2016) (86)
Crosstalk between components of the innate immune system: promoting anti‐microbial defenses and avoiding immunopathologies (2009) (85)
Complement factor P is a ligand for the natural killer cell–activating receptor NKp46 (2017) (85)
Differential responses of immune cells to type I interferon contribute to host resistance to viral infection. (2012) (85)
The Role of Natural Killer Cells in Sepsis (2011) (84)
Multifaceted roles of MHC class I and MHC class I–like molecules in T cell activation (2001) (84)
IL-4 Confers NK Stimulatory Capacity to Murine Dendritic Cells: A Signaling Pathway Involving KARAP/DAP12-Triggering Receptor Expressed on Myeloid Cell 2 Molecules1 (2004) (82)
Tuning the threshold of natural killer cell responses. (2013) (82)
Strategies of natural killer cell recognition and signaling. (2006) (81)
Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and inhibition of cell proliferation. (2003) (80)
DAP12 Signaling Directly Augments Proproliferative Cytokine Stimulation of NK Cells during Viral Infections1 (2006) (79)
Dendritic cells (DC) promote natural killer (NK) cell functions: dynamics of the human DC/NK cell cross talk. (2002) (79)
T-bet-dependent NKp46+ innate lymphoid cells regulate the onset of TH17-induced neuroinflammation (2017) (76)
Inhibition of IgE-mediated mast cell activation by the paired Ig-like receptor PIR-B. (2001) (75)
Stimulation of protein tyrosine phosphorylation in human B cells after ligation of the beta 1 integrin VLA-4. (1993) (75)
Structural similarity between Fc receptors and T cell receptors. Expression of the gamma-subunit of Fc epsilon RI in human T cells, natural killer cells and thymocytes. (1991) (74)
Association of a 70‐kDa tyrosine phosphoprotein with the CD16:ζ:γ complex expressed in human natural killer cells (1993) (74)
What is natural in natural killer cells? (2006) (73)
T cell regulation of natural killer cells (2013) (73)
Transforming growth factor–β and Notch ligands act as opposing environmental cues in regulating the plasticity of type 3 innate lymphoid cells (2016) (72)
Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages. (2005) (72)
Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo (2009) (71)
Differential regulation of killer cell Ig‐like receptors and CD94 lectin‐like dimers on NK and T lymphocytes from HIV‐1‐infected individuals (1999) (71)
Association of Killer Cell Immunoglobulin-Like Receptor Genes with Hodgkin's Lymphoma in a Familial Study (2007) (70)
Mapping of NKp46+ Cells in Healthy Human Lymphoid and Non-Lymphoid Tissues (2012) (70)
G-protein-coupled receptors in control of natural killer cell migration. (2011) (70)
Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials (2016) (67)
Phenotype and Functions of Natural Killer Cells in Critically-Ill Septic Patients (2012) (66)
Interactions between Human NK Cells and Macrophages in Response to Salmonella Infection1 (2009) (65)
Selective control of membrane ruffling and actin plaque assembly by the Rho GTPases Rac1 and CDC42 in FcepsilonRI-activated rat basophilic leukemia (RBL-2H3) cells. (1997) (63)
Protection from Inflammatory Organ Damage in a Murine Model of Hemophagocytic Lymphohistiocytosis Using Treatment with IL-18 Binding Protein (2012) (61)
A role for interleukin-12/23 in the maturation of human natural killer and CD56+ T cells in vivo. (2008) (61)
Regulatory natural killer cells: new players in the IL-10 anti-inflammatory response. (2009) (61)
Intrasplenic trafficking of natural killer cells is redirected by chemokines upon inflammation (2008) (61)
Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent anti-tumor immunity in melanoma (2021) (60)
Dissection of the Role of PfEMP1 and ICAM-1 in the Sensing of Plasmodium falciparum-Infected Erythrocytes by Natural Killer Cells (2007) (60)
Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions (2004) (58)
The immunological functions of the Appendix: An example of redundancy? (2018) (57)
Coordination of activating and inhibitory signals in natural killer cells. (2005) (56)
The discontinuity theory of immunity (2016) (56)
Inherited IL-18BP deficiency in human fulminant viral hepatitis (2019) (55)
Natural Killer Cells: From Basic Research to Treatments (2011) (55)
SnapShot: Natural Killer Cells (2020) (55)
High mTOR activity is a hallmark of reactive natural killer cells and amplifies early signaling through activating receptors (2017) (54)
Germ-line and rearranged Tcrd transcription distinguish bona fide NK cells and NK-like gammadelta T cells. (2007) (54)
Low Circulating Natural Killer Cell Counts are Associated With Severe Disease in Patients With Common Variable Immunodeficiency (2016) (53)
Cell cycle progression dictates the requirement for BCL2 in natural killer cell survival (2017) (52)
Education of Murine NK Cells Requires Both cis and trans Recognition of MHC Class I Molecules (2013) (52)
Biology of immunoreceptor tyrosine-based inhibition motif-bearing molecules. (1999) (52)
Liver type 1 innate lymphoid cells develop locally via an interferon-γ–dependent loop (2021) (52)
The 'T-cell-ness' of NK cells: unexpected similarities between NK cells and T cells. (2011) (51)
Mouse CD146/MCAM is a marker of natural killer cell maturation (2008) (51)
Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19 (2020) (50)
Germ‐line and rearranged Tcrd transcription distinguish bona fide NK cells and NK‐like γδ T cells (2007) (50)
Therapeutic blockade of activin-A improves NK cell function and antitumor immunity (2018) (50)
Immunoregulatory functions of paf-acether. IV. Enhancement of IL-1 production by muramyl dipeptide-stimulated monocytes. (1990) (49)
Differentiation and function of group 3 innate lymphoid cells, from embryo to adult. (2015) (47)
FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B‐cell chronic lymphocytic leukemia (2008) (47)
Cancer cells induce immune escape via glycocalyx changes controlled by the telomeric protein TRF2 (2019) (47)
Natural killer cells and malaria (2006) (47)
Host resistance to endotoxic shock requires the neuroendocrine regulation of group 1 innate lymphoid cells (2017) (46)
Natural killer cell-based therapies (2011) (45)
Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12 (2005) (45)
Massive inflammatory syndrome and lymphocytic immunodeficiency in KARAP/DAP12‐transgenic mice (2002) (44)
Natural killer cell engagers in cancer immunotherapy: Next generation of immuno‐oncology treatments (2021) (44)
NK cell–derived GM-CSF potentiates inflammatory arthritis and is negatively regulated by CIS (2020) (44)
Signaling function of reconstituted CD16: ζ:γ receptor complex isoforms (1992) (44)
Natural killer cell acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw3 specific killer cell inhibitory receptor (CD158b) (1997) (44)
Interferon-&ggr; production by natural killer cells and cytomegalovirus in critically ill patients* (2012) (43)
Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia (2020) (43)
A Pathogen Receptor on Natural Killer Cells (2002) (42)
Different roles for the Fc epsilon RI gamma chain as a function of the receptor context (1995) (42)
NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients (2017) (42)
The B 7 family member B 7-H 6 is a tumor cell ligand for the activating natural killer cell receptor NKp 30 in humans (2009) (41)
NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions (2016) (41)
Activating and inhibitory receptors expressed on innate lymphoid cells (2018) (40)
A high-resolution view of NK-cell receptors: structure and function. (2000) (40)
A novel developmental and immunodeficiency syndrome associated with intrauterine growth retardation and a lack of natural killer cells. (2004) (40)
CD2 is functionally linked to the ζ‐natural killer receptor complex (1991) (39)
Innate Lymphoid Cells in Cancer (2015) (39)
Evidence for Early Infection of Nonneoplastic Natural Killer Cells by Epstein-Barr Virus (2002) (39)
Immunoregulatory functions of paf-acether. I. Effect of paf-acether on CD4+ cell proliferation. (1988) (38)
Single-cell transcriptomic landscape reveals tumor specific innate lymphoid cells associated with colorectal cancer progression (2021) (37)
Association of signal-regulatory proteins beta with KARAP/DAP-12. (2000) (37)
Expansion and Function of CD8+ T Cells Expressing Ly49 Inhibitory Receptors Specific for MHC Class I Molecules1 (2004) (37)
Neuroendocrine regulation of innate lymphoid cells (2018) (37)
The Innate Part of the Adaptive Immune System (2019) (36)
SHIP1 Intrinsically Regulates NK Cell Signaling and Education, Resulting in Tolerance of an MHC Class I–Mismatched Bone Marrow Graft in Mice (2015) (36)
Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis (2020) (36)
Developmental regulation of a mucinlike glycoprotein selectively expressed on natural killer cells (1993) (35)
Innate lymphoid cells and cancer (2022) (35)
CD antigens 2002. (2002) (35)
Manufacturing Natural Killer Cells as Medicinal Products (2016) (35)
The transcription factor Rfx7 limits metabolism of NK cells and promotes their maintenance and immunity (2018) (34)
Complement cascade in severe forms of COVID‐19: Recent advances in therapy (2020) (34)
Genetic Depletion or Hyperresponsiveness of Natural Killer Cells Do Not Affect Atherosclerosis Development (2018) (34)
Features and distribution of CD8 T cells with human leukocyte antigen class I–specific receptor expression in chronic hepatitis C (2007) (34)
ILC2 memory: Recollection of previous activation (2018) (34)
Modulation of T-cell functions in KIR2DL3 (CD158b) transgenic mice. (1999) (33)
Dok1 and Dok2 proteins regulate natural killer cell development and function (2014) (33)
Natural killer cell tolerance: control by self or self-control? (2012) (33)
Familial NK Cell Deficiency Associated with Impaired IL-2- and IL-15-Dependent Survival of Lymphocytes1 (2006) (32)
Evidence for involvement of beta-glucan-binding cell surface lectins in human natural killer cell function. (1994) (32)
DAP12 Signaling Regulates Plasmacytoid Dendritic Cell Homeostasis and Down-Modulates Their Function during Viral Infection1 (2006) (32)
A Nomenclature for Signal Regulatory Protein Family Members (2005) (32)
Altered distribution and function of natural killer cells in murine and human Niemann-Pick disease type C1. (2014) (32)
Natural killers or ILC1s? That is the question. (2020) (32)
The PEN5 epitope identifies an oligodendrocyte precursor cell population and pilocytic astrocytomas. (1999) (30)
DAP12 signaling regulates plasmacytoid dendritic cell homeostasis and down-modulates their function during viral infection. (2006) (29)
Normal development and function of natural killer cells in CD3 epsilon delta 5/delta 5 mutant mice. (1995) (29)
Expression of MHC class I receptors confers functional intraclonal heterogeneity to a reactive expansion of γδ T cells (2005) (28)
NK Cell–Specific Gata3 Ablation Identifies the Maturation Program Required for Bone Marrow Exit and Control of Proliferation (2016) (28)
Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells. (2010) (27)
Trans-inhibition of activation and proliferation signals by Fc receptors in mast cells and basophils (2016) (27)
Innate lymphoid cells: parallel checkpoints and coordinate interactions with T cells. (2016) (26)
Inborn errors of the development of human natural killer cells (2013) (26)
Chemotherapy and tumor immunity (2018) (25)
Distribution of killer-cell immunoglobulin-like receptor (KIR) in Comoros and Southeast France. (2006) (25)
CD antigens 2001 (2001) (25)
Shp-2 is critical for ERK and metabolic engagement downstream of IL-15 receptor in NK cells (2019) (25)
NK cell development: Gas matters (2006) (24)
Agrin--A Bridge Between the Nervous and Immune Systems (2001) (24)
Factors Associated with Post-Seasonal Serological Titer and Risk Factors for Infection with the Pandemic A/H1N1 Virus in the French General Population (2013) (24)
Natural killer cell acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw3 specific killer cell inhibitory receptor. (1997) (24)
NK cell genesis: a trick of the trail. (2012) (24)
The CD8β polypeptide is required for the recognition of an altered peptide ligand as an agonist (1996) (23)
Immunoregulatory functions of paf-acether. VIII. Inhibition of IL-4-induced human IgE synthesis in vitro. (1992) (23)
Natural killer cells are required for extramedullary hematopoiesis following murine cytomegalovirus infection. (2013) (23)
Identification of the E3 Ligase TRIM29 as a Critical Checkpoint Regulator of NK Cell Functions (2019) (23)
Impact of β2 integrin deficiency on mouse natural killer cell development and function. (2011) (22)
Editorial: NK Cell Subsets in Health and Disease: New Developments (2017) (21)
Lung Natural Killer Cells Play a Major Counter-Regulatory Role in Pulmonary Vascular Hyperpermeability After Myocardial Infarction (2014) (21)
Engagement of natural cytotoxicity programs regulates AP-1 expression in the NKL human NK cell line. (1999) (21)
Contrasting roles of DAP10 and KARAP/DAP12 signaling adaptors in activation of the RBL‐2H3 leukemic mast cell line (2003) (21)
Selective control of membrane ruffling and actin plaque assembly by the Rho GTPases Rac 1 and CDC 42 in Fc ε RI-activated rat basophilic leukemia ( RBL-2 H 3 ) cells (1997) (20)
Reconstitution of CD3 zeta coupling to calcium mobilization via genetic complementation. (1994) (20)
Mycotic aneurysm of the carotid artery due to Salmonella enteritidis associated with multiple brain abscesses. (1996) (20)
Association of a 70-kDa tyrosine phosphoprotein with the CD16: zeta: gamma complex expressed in human natural killer cells. (1993) (19)
Analysis of donor NK and T cells infused in patients undergoing MHC-matched allogeneic hematopoietic transplantation (2002) (19)
Integrative study of pandemic A/H1N1 influenza infections: design and methods of the CoPanFlu-France cohort (2012) (19)
Immunoregulatory functions of paf‐acether II. Decrease of CD2 and CD3 antigen expression (1988) (19)
Helper-like innate lymphoid cells and cancer immunotherapy. (2019) (18)
Immune checkpoints on innate lymphoid cells (2017) (18)
Good news, bad news for missing-self recognition by NK cells: autoimmune control but viral evasion. (2007) (18)
Natural Killer Cell Receptor Signaling Pathway (2005) (18)
Structure and function of the CD16:zeta:gamma complex expressed on human natural-killer cells. (1992) (18)
Rapid loss of group 1 innate lymphoid cells during blood stage Plasmodium infection‡ (2018) (18)
Infection of human natural killer (NK) cells with replication-defective human T cell leukemia virus type I provirus. Increased proliferative capacity and prolonged survival of functionally competent NK cells. (1992) (17)
NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functions. (2021) (17)
Immunoregulatory functions of paf-acether. VI. Inhibition of T cell activation via CD3 and potentiation of T cell activation via CD2. (1990) (17)
ADAPted secretion of cytokines in NK cells (2013) (16)
Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on BRAFV600E Melanoma Lines with Vemurafenib (2017) (16)
Wireless capsule video endoscopy: a new diagnostic method for aortoduodenal fissure. (2002) (16)
Occult Thyrotoxicosis in Patients with Atrial Fibrillation and an Acute Arterial Embolism (1988) (15)
[Aneurysms of the popliteal artery]. (1972) (15)
When NK cells overcome their lack of education. (2012) (15)
Maternal diesel particle exposure promotes offspring asthma through NK cell-derived granzyme B. (2020) (15)
Expression of the CD85j (leukocyte Ig-like receptor 1, Ig-like transcript 2) receptor for class I major histocompatibility complex molecules in idiopathic inflammatory myopathies. (2008) (15)
Expression and tyrosine phosphorylation of the T cell receptor zeta-subunit in human thymocytes. (1991) (14)
Immunology: Natural killer cells remember (2009) (14)
Induction of B 7-H 6 , a ligand for the natural killer cell – activating receptor NKp 30 , in in fl ammatory conditions (2013) (14)
Signaling function of reconstituted CD16: zeta: gamma receptor complex isoforms. (1992) (14)
Expression of MHC class I receptors confers functional intraclonal heterogeneity to a reactive expansion of gammadelta T cells. (2005) (13)
Role of NKp46+ natural killer cells in house dust mite‐driven asthma (2018) (13)
Natural-Killer-like B Cells Display the Phenotypic and Functional Characteristics of Conventional B Cells. (2017) (13)
Identity , regulation and in vivo function of gut NKp 46 þ ROR c t þ and NKp 46 þ ROR c t lymphoid cells (2011) (13)
[NK cells and innate immunity to malaria]. (2006) (12)
Identification of tissue-infiltrating lymphocytes expressing PEN5, a mucin-like glycoprotein selectively expressed on natural killer cells. (1995) (12)
NK Cell Subsets in Health and Disease: New Developments (2017) (12)
Hydatid cyst fistula into the aorta. (1989) (12)
CD2 triggering stimulates the formation of platelet-activating factor-acether from alkyl-arachidonoyl-glycerophosphocholine in a human CD4+ T lymphocyte clone. (1992) (12)
Combination blockade of KLRG1 and PD-1 promotes immune control of local and disseminated cancers (2021) (12)
The ubiquitin-editing enzyme A20 controls NK cell homeostasis through regulation of mTOR activity and TNF (2019) (12)
Pre-clinical characterization of 1-7F9, a novel human anti-KIR therapeutic antibody that augments NK-mediated killing of tumor cells (2009) (12)
CD2 is functionally linked to the zeta-natural killer receptor complex. (1991) (12)
Reference: CD Antigens 20021 (2002) (11)
Inflammation-Induced Lactate Leads to Rapid Loss of Hepatic Tissue-Resident NK Cells. (2020) (11)
Multidimensional molecular controls defining NK/ILC1 identity in cancers. (2020) (11)
Lessons from NK Cell Deficiencies in the Mouse. (2016) (11)
Function of killer cell inhibitory receptors for MHC class I molecules. (1996) (11)
LBA53 Precision immuno-oncology for advanced non-small cell lung cancer (NSCLC) patients (pts) treated with PD1/L1 immune checkpoint inhibitors (ICIs): A first analysis of the PIONeeR study (2020) (10)
Natural Killer Cell Receptor Signaling Pathway in Mammals (2005) (10)
Murine peripheral NK‐cell populations originate from site‐specific immature NK cells more than from BM‐derived NK cells (2016) (10)
c-FLIP is crucial for IL-7/IL-15-dependent NKp46+ ILC development and protection from intestinal inflammation in mice (2020) (10)
Structural Insights into the Inhibitory Mechanism of an Antibody against B7-H6, a Stress-Induced Cellular Ligand for the Natural Killer Cell Receptor NKp30. (2016) (10)
Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia (2022) (10)
Expression of a NK cell-restricted epitope on decidual large granular lymphocytes. (1996) (9)
How to Extinguish Lymphocyte Activation, Immunotyrosine-Based Inhibition Motif (ITIM)-Bearing Molecules a Solution? (1999) (9)
Expression, crystallization and X-ray diffraction analysis of a complex between B7-H6, a tumor cell ligand for the natural cytotoxicity receptor NKp30, and an inhibitory antibody. (2015) (9)
Cutting Edge: Murine NK Cells Degranulate and Retain Cytotoxic Function without Store-Operated Calcium Entry (2017) (9)
Author Correction: Natural killer cells and other innate lymphoid cells in cancer (2018) (9)
A point mutation in the Ncr1 signal peptide impairs the development of innate lymphoid cell subsets (2018) (9)
Anti-tumoral efficacy of therapeutic human anti-KIR antibody (Lirilumab/BMS-986015/IPH2102) in a preclinical xenograft tumor model (2013) (9)
Immunobiology of Natural Killer Cell Receptors (2006) (8)
[B7-H6 : a novel alert signal for NK cells]. (2010) (8)
Group 1 ILCs regulate T cell–mediated liver immunopathology by controlling local IL-2 availability (2022) (8)
Increased diabetes development and decreased function of CD4+CD25+ Treg in the absence of a functional DAP12 adaptor protein (2008) (8)
Type 1 Innate Lymphoid Cells Limit the Antitumoral Immune Response (2021) (8)
Immuno-Oncology beyond TILs: Unleashing TILCs. (2020) (8)
Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity (2021) (7)
Crystal Structure of the Human Natural Killer Cell Activating Receptor KIR 2 DS 2 ( CD 158 j ) (2003) (7)
Campylobacter infection promotes IFNγ-dependent intestinal pathology via ILC3 to ILC1 conversion (2020) (7)
Shed NKG2D ligand boosts NK cell immunity (2015) (7)
Publisher Correction: Harnessing innate immunity in cancer therapy (2019) (7)
The discovery of innate lymphoid cells (2021) (7)
Clues that natural killer cells help to control COVID (2021) (7)
IMMUNOBIOLOGY Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD 20 antibodies (2014) (7)
Immunoregulatory functions of paf-acether (platelet-activating factor). (1988) (6)
Production of PAF-acether and leukotrienes by cultured mouse macrophages. (1986) (6)
Immunology. Agrin--a bridge between the nervous and immune systems. (2001) (6)
CD Antigens 2001: Aims and Results of HLDA Workshops (2001) (6)
Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE])* (2022) (6)
Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling Donor (2020) (6)
Corrigendum : T cell killing does not require the formation of a stable mature immunological synapse (2002) (6)
Administration of interleukin 13 to simian immunodeficiency virus-infected macaques: induction of intestinal epithelial atrophy. (1998) (6)
Advances in Brief Decreased Expression of the Signal-transducing Chains in Tumor-infiltrating T-Cells and NK Cells of Patients with Colorectal Carcinoma (2007) (6)
Natural killer cells lull tumours into dormancy (2021) (6)
The Abl‐1 Kinase is Dispensable for NK Cell Inhibitory Signalling and is not Involved in Murine NK Cell Education (2017) (6)
The enigma of activating isoforms of ITIM-bearing molecules. (1999) (6)
NKG2D–MICA Interaction: A Paradigm Shift in Innate Recognition (2018) (6)
Crk Adaptor Proteins Regulate NK Cell Expansion and Differentiation during Mouse Cytomegalovirus Infection (2018) (6)
[Effect of peripheral parenteral nutrition on the immediate postoperative period in surgery of the aortic sector]. (1989) (5)
[NK cells: new insights on physiology and clinical implication in diseases]. (2006) (5)
Biosynthesis of paf-acether. Paf-acether but not leukotriene C4 production is impaired in cultured macrophages. (1989) (5)
Erratum and corrigendum: Innate and adaptive immunity: specificities and signaling hierarchies revisited (2005) (5)
Delivering Three Punches to Knockout Intracellular Bacteria (2014) (5)
Role of the ITAM-Bearing Receptors Expressed by Natural Killer Cells in Cancer (2022) (5)
Maturation of Mouse NK Cells is a Four-stage Developmental Program (2010) (5)
Correction: NK cell–derived GM-CSF potentiates inflammatory arthritis and is negatively regulated by CIS (2020) (5)
Abstract 2714: Combination of monalizumab and durvalumab as a potent immunotherapy treatment for solid human cancers (2018) (5)
Reply to ‘Comment on: Evidence of innate lymphoid cell redundancy in humans’ (2018) (5)
Identification of immune checkpoints in COVID-19 (2020) (5)
Tumor Microenvironment-Derived R-spondins Enhance Anti-Tumor Immunity to Suppress Tumor Growth and Sensitize for Immune Checkpoint Blockade Therapy. (2021) (4)
Nfil 3-independent lineage maintenance and antiviral response of natural killer cells (2013) (4)
Modulation of T-Cell Functions in KIR 2 DL 3 ( CD 158 b ) Transgenic Mice (1999) (4)
Natural Killer Cells (2016) (4)
Signalling through the TCR. (1998) (4)
Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant (2022) (4)
Innate lymphoid cell recovery and occurrence of GvHD after hematopoietic stem cell transplantation (2021) (4)
Loss of HIF-1α in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesis (2017) (4)
Strategies of Natural Killer (NK) Cell Recognition and Their Roles in Tumor Immunosurveillance (2008) (4)
Les cellules natural killer : acquisitions récentes et implication en pathologie humaine (2006) (4)
CD Antigens 2001 (2002) (3)
CISH targeting in NK cells activates natural cytotoxicity receptor signaling and reduce cell exhaustion to unsilence primary anti-tumor response (2022) (3)
Correction: KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions, Vol 35 (6) 2005, DOI 10.1002/eji.200425932 (2005) (3)
Tissue-specific transcriptional profiles and heterogeneity of natural killer cells and group 1 innate lymphoid cells (2022) (3)
[Natural killer cells: adaptation and memory in innate immunity]. (2013) (3)
CD antigens 2001 (2001) (3)
Advancing natural killer therapies against cancer (2022) (3)
ILC3s control splenic cDC homeostasis via lymphotoxin signaling (2021) (3)
Corrigendum: Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D (2004) (3)
1O Harnessing innate immunity in cancer therapies: The example of natural killer cell engagers (2021) (3)
BIAcore analysis to test phosphopeptide-SH2 domain interactions. (2000) (3)
Genetic Dissection of the Transducing Subunits of the T‐Cell Antigen Receptor (1995) (3)
Immunoregulatory functions of paf-acether. VI. Dual effect on human B cell proliferation (1991) (3)
Safety of Anti-NKG2A Blocking Antibody Monalizumab As Maintenance Therapy after Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Study (2021) (3)
HLA-Fatal attraction (2016) (2)
Editorial overview: Innate immunity. (2016) (2)
Feasibility and safety of allogeneic ex vivo activated-NK cell infusion after matched related hematopoietic stem cell transplantation: Preliminary results of a prospective phase I trial (2017) (2)
Bringing natural killer cells to the clinic (2022) (2)
Correction: Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia (2021) (2)
Inhibitory and activatory receptors for MHC class I molecules. (1997) (2)
Natural killer cells and type 1 innate lymphoid cells in cancer. (2023) (2)
Author response: High mTOR activity is a hallmark of reactive natural killer cells and amplifies early signaling through activating receptors (2017) (2)
Boosting Cytotoxic Antibodies against Cancer (2020) (2)
Faculty Opinions recommendation of Licensing of natural killer cells by host major histocompatibility complex class I molecules. (2005) (2)
Reply to ‘Comment to: Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia’ (2021) (2)
Coincidence detection of antibodies and interferon for sensing microbial context (2014) (2)
Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123. (2023) (2)
Natural killer cell acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw 3 specific killer cell inhibitory receptor ( CD 158 b ) (1997) (2)
Dissection of the role of PfEMP 1 and ICAM-1 in the sensing of plasmodium falciparum-infected erythrocytes by natural killer cells (2018) (2)
[Aneurysm of the abdominal aorta and horseshoe kidney. Apropos of a case]. (1986) (2)
Book Review: A Widely Conserved Smell of Danger (2003) (2)
CD antigens 2001 (2001) (2)
Avdoralimab (anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FORCE) (2022) (1)
A NOVEL POPULATION OF INTESTINAL INTRA-EPITHELIAL LYMPHOCYTES EXPRESSING THE NATURAL KILLER MARKER, CD94, IS CORRELATED WITH VILLOUS ATROPHY IN CHILHOOD CELIAC DISEASE. (1997) (1)
NK Cell-Based Therapies (2018) (1)
Therapeutic considerations and results in 336 arterial emboli. (1973) (1)
[Infection in dacron grafts]. (1981) (1)
SHP2 tyrosine phosphatase associates with SST2 somatostatin receptor (1998) (1)
Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis (2020) (1)
CD antigens 2001. (2001) (1)
Checkers Is Solved (2007) (1)
Myc controls IL-15-driven expansion and translational machinery of NK cells (2022) (1)
Author Correction: T-bet-dependent NKp46+ innate lymphoid cells regulate the onset of TH17-induced neuroinflammation (2018) (1)
T-bet-dependent NKp46+ innate lymphoid cells regulate the onset of TH17-induced neuroinflammation (2017) (1)
Science Signaling Podcast for 3 May 2016: Innate lymphoid cell plasticity (2016) (1)
[Non-invasive monitoring of cardiac output with Doppler in aortoiliac surgery. Preliminary study]. (1989) (1)
P1.04-30 Pioneer Study: Precision Immuno-Oncology for Advanced Non-Small Cell Lung Cancer Patients with PD1/L1 ICI Resistance (2019) (1)
[Findings and results in surgery of cancer of the esophagus]. (1970) (1)
Role of the KLRG1 pathway during the immune response to cancer (2020) (1)
CD Antigens 2001. (2000) (1)
Killer ILCs in the Fat. (2017) (1)
Chylous ascites: a rare complication following aortic surgery. (1993) (1)
Abstract 1690: NKG2A immune checkpoint blockade potentiates cetuximab induced ADCC in head and neck cancer preclinical model (2018) (1)
A comprehensive approach to gene expression profiling in immune cells. (2020) (1)
CD antigens 2001. (2001) (1)
Dok 1 and Dok 2 proteins regulate natural killer cell development and function (2014) (1)
Tolerogenic dendritic cells: a KARAP/DAP12–IRF-8/ICSBP balance (2006) (1)
[Arterial obliteration of the upper extremity. Commentary apropos of 3 cases]. (1966) (1)
T Cells + Cytotoxic Function in Human CD8 MHC Class I Receptors and Acquisition of Coordinated Expression of Ig-Like Inhibitory (2004) (1)
852 Trifunctional NKp46/CD16a-NK cell engager targeting CD123 overcomes acute myeloid leukemia resistance to ADCC (2021) (1)
Differential Roles of Nand C-Terminal Immunoreceptor Tyrosine-Based Inhibition Motifs During Inhibition of Cell Activation by Killer Cell Inhibitory Receptors 1 (1999) (1)
Since their identification 40 years ago, natural killer (NK) cells write a never-ending story. Introduction. (2016) (0)
Table of Contents (1995) (0)
This information is current as Bone Marrow Graft in Mice Mismatched - Tolerance of an MHC Class I Signaling and Education, Resulting in SHIP1 Intrinsically Regulates NK Cell (2015) (0)
Reply to ‘Comment on: Evidence of innate lymphoid cell redundancy in humans’ (2018) (0)
Abstract 493: Antitumoral efficacy of therapeutic human anti-KIR antibody (BMS-986015/IPH2102) in a preclinical xenograft tumor model. (2013) (0)
Absence of NK Cells Leads to Enhanced T Cell Priming in the + Cutting Edge: CD8 (2011) (0)
Shp-2 is critical for ERK and metabolic engagement downstream of IL-15 receptor in NK cells (2019) (0)
Faculty Opinions recommendation of The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. (2009) (0)
Normal development and function of natural killer cells in CD3E5 /A5 mutant mice (2005) (0)
Disease The Immunogenetic Architecture of Autoimmune An Goris and Adrian Liston Self-Control ? Natural Killer Cell Tolerance : Control by Self or (2012) (0)
Lymphohistiocytoses hémophagocytaires acquises de l’adulte : lymphopénie transitoire sans déficit de cytotoxicité lymphocytaire NK (2017) (0)
[Innate Lymphoid Cells: new actors of immunity]. (2016) (0)
Manipulating Interleukin-15 and Transforming Growth Factor-β Signaling Augments Natural Killer Cell Homeostasis and Protects from Experimental Pulmonary Arterial Hypertension (2020) (0)
Regulation of synaptic properties by the microglial protein DAP12/KARAP (2006) (0)
Tm1 cells, a subset of T cells with NK cell and memory CD8 T‐cell features (2003) (0)
IPH6501 Is a Novel NKp46-Targeting Tetraspecific Antibody-Based Natural Killer Cell Engager Therapeutic (ANKET) Armed with a Non-Alpha IL-2 Variant and Developed for the Treatment of CD20-Positive Malignancies (2022) (0)
Surgical treatment of reno-vascular hypertension. (1973) (0)
Reply to ‘Comment to: Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia’ (2021) (0)
Differential roles of ROR gamma-t in the development of NKp46+ spleen (LTIL) cells and NKp46+ NK cells in gut and skin (2010) (0)
["Immune checkpoint inhibitors in oncology"]. (2021) (0)
Education and tuning of natural killer cells (2009) (0)
The transcription factor Rfx7 limits metabolism of NK cells and promotes their maintenance and immunity (2018) (0)
New polypeptide that restores activity of killer cell activatory receptor (1998) (0)
NK cells as modulators of tumor angiogenesis (2010) (0)
Faculty Opinions recommendation of Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. (2006) (0)
Distribution of natural killer cell immunoglobulin-like genes in south-eastern French and Comorian populations (2004) (0)
Natural killer cell engagers in cancer immunotherapy: Next generation of immunoâ•’oncology treatments<inlineGraphic alt='image' href='urn:x-wiley:00149028:media:eji5119:eji5119-gra-0002' location='graphic/eji5119-gra-0002.png'></inlineGraphic> (2021) (0)
Responses Absence of NK Cells Leads to Enhanced Memory T Cell Priming in the + Cutting Edge: CD8 (2011) (0)
Activating and inhibitory receptors expressed on innate lymphoid cells (2018) (0)
L’immunologie en question (2001) (0)
Targeting MICA/B with cytotoxic therapeutic antibodies leads to tumor control [version 2; peer review: 2 approved] (2021) (0)
190P Combination of IPH5201, a blocking antibody targeting the CD39 immunosuppressive pathway, with durvalumab and chemotherapies: Preclinical rationale (2022) (0)
[Involvement of the complement cascade in severe forms of COVID-19]. (2021) (0)
ISACs take a Toll on tumors (2020) (0)
Cancer Biology (2013) (0)
Corrigendum to ?Coordination of activating and inhibitory signals in natural killer cells? [Mol. Immunol. 42 (2005) 477?484] (2005) (0)
Natural Killer Cell TGFβ Signalling Influences Pulmonary Vascular Development and Pathological Vascular Remodelling in a Mouse Model of Pulmonary Arterial Hypertension (2022) (0)
Specific for MHC Class I Molecules Expressing Ly 49 Inhibitory Receptors T Cells + Expansion and Function of CD 8 Brossay and (2004) (0)
Spinal cord stimulation - Multicentral spanish study (1994) (0)
Correction (2021) (0)
[Capillaroscopic observation in angiologic diagnosis]. (1990) (0)
[Treatment of arteriosclerotic lesions by means of by-pass of the femoral-popliteal sector in diabetic patients]. (1974) (0)
CD56+ T cells in vivo A role for interleukin-12/23 in the maturation of human natural killer and (2013) (0)
ITIMs: episode 1 of the inhibitory saga (2017) (0)
Evidence of innate lymphoid cell redundancy in humans (2016) (0)
[Use of thermography in the detection of deep venous thrombosis]. (1988) (0)
Natural Killer Cell Proliferation Requires Canonical IRE1 Function During Viral Infection (2022) (0)
Correction to: Campylobacter infection promotes IFNγ-dependent intestinal pathology via ILC3 to ILC1 conversion (2021) (0)
[Findings and results in surgery of cancer of the esophagus]. (1970) (0)
Evaluation of Indium-111 Antifibrin Monoclonal Antibody Imaging in Deep Venous Thrombosis Diagnosis (1992) (0)
Trifunctional antibodies unleash NK cells (2019) (0)
[New frontiers in the fight against cancer]. (2018) (0)
Faculty Opinions recommendation of The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells. (2014) (0)
Sophie Viaud of Cyclophosphamide The Intestinal Microbiota Modulates the Anticancer Immune Effects (2013) (0)
Characterization of Tm1 cells, a NKR + subset of memory-phenotype CD8 + T cells (2001) (0)
Faculty Opinions recommendation of Identification of human NK cells that are deficient for signaling adaptor FcRγ and specialized for antibody-dependent immune functions. (2013) (0)
[Aneurysms of the upper extremities]. (1974) (0)
Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19 (2020) (0)
False peripheral aneurysm following direct arterial surgery. (1973) (0)
Faculty Opinions recommendation of Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity. (2004) (0)
[Clinical features and surgical management of Leriche's syndrome (author's transl)]. (1975) (0)
[Venous aneurysm]. (1969) (0)
Targeting natural killer cells in solid tumors (2019) (0)
Myc controls NK cell development, IL-15-driven expansion, and translational machinery (2023) (0)
Natural Killer (NK) Cells (2010) (0)
Abstract P051: Function of shp-1 and shp-2 phosphatases in T cell-mediated anti-tumor response (2022) (0)
Features and Distribution of CD8 T cells with HLA Class I Specific Receptor Expression in Chronic Hepatitis C. (2009) (0)
Cellular aspects of lymphoid differentiation: T and NK cells (2004) (0)
[Surgery of chronic abdominal vascular insufficiency]. (1973) (0)
44 The overexpression of DAP12 leads to gain of osteoclast function in vitro with age-related onset of ostepenia in vivo (2008) (0)
Viral Infection Down-Modulates Their Function during Dendritic Cell Homeostasis and DAP 12 Signaling Regulates Plasmacytoid (2006) (0)
[Clinical study and surgical treatment of Leriche's syndrome]. (1975) (0)
Faculty Opinions recommendation of Urochordates and the origin of natural killer cells: identification of a CD94/NKR-P1-related receptor in blood cells of Botryllus. (2003) (0)
[Arterial traumatism]. (1974) (0)
Down-Modulates Their Function during Dendritic Cell Homeostasis and DAP12 Signaling Regulates Plasmacytoid (2014) (0)
Rearrangements Occurs in T Cells After Termination of TCR Killer-Cell Ig-Like Receptor Expression Regulation of Inhibitory and Activating (2001) (0)
Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2 (2019) (0)
This information is current as Marrow Exit and Control of Proliferation the Maturation Program Required for Bone Specific Gata 3 Ablation Identifies − (2016) (0)
EditorialIntroduction: complexity, specialization and recognition (2004) (0)
Molecules Receptor Expressed on Myeloid Cell 2 Involving KARAP / DAP 12-Triggering PathwayMurine Dendritic Cells : A Signaling IL-4 Confers NK Stimulatory Capacity to (2004) (0)
For natural killer cell-specific antigenic and identifying antibodies (1994) (0)
CellsExpressed on Human Monocytes and NK Siglecs-7 and -9, CD33-Related Siglecs for the Inhibitory Signaling Mediated by Tyrosine-Based Inhibitory Motif Is Critical The Membrane-Proximal Immunoreceptor (2004) (0)
NKG2A blocks the anti-metastatic functions of natural killer cells. (2023) (0)
A novel mucosal RORγt+NKp46+ cell subset is a source of interleukin-22 (2009) (0)
CD8 (cid:98) Increases CD8 Coreceptor Function and Participation in TCR–Ligand Binding (1996) (0)
[Aortobifemoral prostheses with "0" porosity. Results after 2 years' experience]. (1990) (0)
Down-Regulation of CD2 and CD3 Antigen Expression by PAF-Acether (1988) (0)
Shp-2 Is Dispensable for E stablishing T Cell Exhaustion and for PD-1 Signaling In Vivo Graphical (2018) (0)
Molecules Recognition of MHC Class I trans and cis Education of Murine NK Cells Requires Both (2013) (0)
C5a-C5aR1 Axis Blockade in Patients With Severe COVID-19: Contrasting Results of PANAMO and FORCE. (2023) (0)
Science Signaling Podcast: 5 April 2011 (2011) (0)
Manipulating Innate Immune Pathways for Cancer Immunotherapy (2021) (0)
Killer Cell Inhibitory Receptors Motifs During Inhibition of Cell Activation by Immunoreceptor Tyrosine-Based Inhibition Differential Roles of Nand C-Terminal (1999) (0)
The Novel Trifunctional Anti-BCMA NK Cell Engager SAR'514 Has Potent in-Vitro and in-Vivo Anti-Myeloma Effect through Dual NK Cell Engagement (2022) (0)
LIGAND DE NKP46 (2018) (0)
Absence of NK Cells Leads to Enhanced Memory T Cell Priming in the + Cutting Edge : CD 8 Data (2011) (0)
CD4 regulatory T cells inhibit natural killer cell functions in a transforming growth factor– (cid:1) –dependent manner (2005) (0)
Comprar Natural Killer Cells (Current Topics In Microbiology And Immunology, Vol. 395) | Eric Vivier | 9783319239156 | Springer (2016) (0)
Cell Line Programs Regulates AP-1 Expression in the Engagement of Natural Cytotoxicity (1999) (0)
Natural killer cells and other innate lymphoid cells in cancer (2018) (0)
Tissue-Specific Imprinting and Heterogeneity of Natural Killer Cells and Group 1 Innate Lymphoid Cells (2022) (0)
Regulation of virus-specific natural killer cell memory by IL-10 and TGF-β (CCR4P.207) (2015) (0)
[Arterial embolism, embolic recurrences and anticoagulant treatment. Retrospective study of 43 patients]. (1988) (0)
Dissection of the role of natural killer cells in atherosclerosis using selective genetic approaches. (2017) (0)
Immune surveillance and tumor immunity (SY2-5) Chairpersons: Takashi Nishimura, Laurence Zitvogel (2010) (0)
852 Natural killer cell deficiency reveals a novel immunotherapy strategy for atopic dermatitis (2020) (0)
Endogenous glucocorticoids control host resistance to viral infection through the tissue-specific regulation of PD-1 expression on NK cells (2018) (0)
[Natural killer cells: promising targets in cancer therapy]. (2019) (0)
Severe peripheral blood lymphopenia without NK cell cytotoxicty deficiency is the rule in adult acquired HLH (2015) (0)
Abstract 2960: The novel trifunctional anti-BCMA NK cell engager SAR’514 has potent in-vitro, in-vivo and ex-vivo anti-myeloma effect through dual NK cell engagement (2023) (0)
Author Correction: Natural killer cells and other innate lymphoid cells in cancer (2018) (0)
Faculty Opinions recommendation of NKG2D-independent suppression of T cell proliferation by H60 and MICA. (2005) (0)
Faculty Opinions recommendation of Continuous engagement of a self-specific activation receptor induces NK cell tolerance. (2008) (0)
Faculty Opinions recommendation of Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. (2003) (0)

This paper list is powered by the following services:

Other Resources About Eric Vivier

en.wikipedia.org

What Schools Are Affiliated With Eric Vivier?

Eric Vivier is affiliated with the following schools:

Image Attributions

Image Source for Eric Vivier